Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine in POTS
NCT03182725Phase 3Completed
- Sponsor
- University of California, San Diego
- Start
- Feb 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivabradine in postural orthostatic tachycardia syndrome (POTS), sponsored by University of California, San Diego. Started Feb 2018; status: completed.
02
Drugs
ivabradine
03
Conditions
postural orthostatic tachycardia syndrome (POTS)
Beyond the preview
Go deeper on NCT03182725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03182725.